Perspective Therapeutics (CATX)
NYSE MKT:CATX
Holding CATX?
Track your performance easily

Perspective Therapeutics (CATX) Financial Statements

1,103 Followers

Perspective Therapeutics Financial Overview

Perspective Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.928; its P/E ratio is -12.12; Perspective Therapeutics is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.21. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 526.00K$ 1.50M$ 2.06M$ 1.83M$ 1.72M
Gross Profit$ 526.00K$ 248.00K$ 487.00K$ 403.00K$ 414.00K
EBIT$ -11.25M$ -10.49M$ -10.85M$ -3.20M$ -4.07M
EBITDA$ -10.68M$ -10.23M$ -10.66M$ -3.20M$ -3.99M
Net Income Common Stockholders$ -11.70M$ -11.11M$ -371.00K$ -2.90M$ -4.07M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 292.87M$ 28.32M$ 36.45M$ 43.76M$ 54.11M
Total Assets$ 385.92M$ 120.14M$ 127.64M$ 58.28M$ 62.54M
Total Debt$ 3.88M$ 2.58M$ 2.12M$ 392.00K$ 458.00K
Net Debt$ -288.99M$ -25.74M$ -34.34M$ -43.37M$ -53.65M
Total Liabilities$ 44.92M$ 11.49M$ 9.62M$ 3.27M$ 4.84M
Stockholders Equity$ 341.00M$ 108.65M$ 118.03M$ 55.01M$ 57.70M
Cash Flow-
Free Cash Flow$ -9.92M$ -8.63M$ -9.92M-$ 56.07M
Operating Cash Flow$ -8.90M$ -8.07M$ -9.72M-$ 56.07M
Investing Cash Flow$ -3.29M$ -573.00K$ 25.26M-$ -35.17M
Financing Cash Flow$ 122.08M$ 512.00K$ -80.00K-$ 28.00K
Currency in USD

Perspective Therapeutics Earnings and Revenue History

Perspective Therapeutics Debt to Assets

Perspective Therapeutics Cash Flow

Perspective Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis